Skip to main content
AN ACT relating to coverage for diabetes treatment.
Summary of Original Version
Amend KRS 304.17A-148 to require that cost sharing for noninsulin drugs and certain equipment and supplies necessary for the treatment of diabetes not exceed certain cost-sharing thresholds; prohibit insurers from conducting or imposing utilization review for diabetes treatment prescribed by a health care provider; EFFECTIVE January 1, 2023.
Introduced .pdf (23.77 KB)
Index Headings of Original Version
Diabetes treatment, insurance requirements, health plan
Diabetes treatment, insurance requirements
Diabetes drugs, equipment, and supplies, cost-sharing limitation
Diabetes treatment, insurance requirements, January 1, 2023
Diabetes treatment, cost-sharing limitation
Diabetes treatment, utilization review prohibition
Diabetes treatment, insurance requirements, health plan
  • Prefiled by the sponsor(s).
  • introduced in House

Support Our Work

The Coalition needs your help in safeguarding Kentuckian's right to know about their government.